Bimatoprost

250, 500 mg Film Coated Tablet

100 µg (200 dose) Nasal Spray

25, 100 mg (IV) Injectable (vial containing lyophilised powder for infusion)

4, 8 mg Film Coated Tablet

50, 150 mg Film Coated Tablet

0.01% Ophthalmic Eye Drops

3 ml LDPE, transparent plastic bottle Eye Drops

3.5 mg Powder for Solution for IV/SC Injection

0.2% Ophthalmic Eye Drops

200 µg, 400 µg Capsule for Inhalation

0.25 mg/ml (2 ml) 0.50 mg/ml (2 ml) Vial Containing Inhalation Susp. for Nebulisation, Single Dose

0,5 mg/2 ml 1 mg/2 ml Solution for Nebulization (single-dose vials)

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.